Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.
about
Peroxisome proliferators: their biological and toxicological effects.Alteration of liver cell function and proliferation: differentiation between adaptation and toxicity.Effects of phthalic acid esters on the liver and thyroidComparative pharmacokinetics and subacute toxicity of di(2-ethylhexyl) phthalate (DEHP) in rats and marmosets: extrapolation of effects in rodents to man.Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drugAn overview of peroxisome proliferator-induced hepatocarcinogenesis.Hepatocyte proliferation induced by a single dose of a peroxisome proliferator.Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis.Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes--conclusions from the 3rd International ESTP Expert Workshop.Comparative aspects of the mammalian cytochrome P450 IV gene family.The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney.Interspecies differences in peroxisomes and peroxisome proliferation.Mechanisms of toxic injury.Biological effects of di-(2-ethylhexyl) phthalate and other phthalic acid esters.Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.Comment on the carcinogenic potential of di(2-ethylhexyl) phthalate.Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.Cancer risk assessment: historical perspectives, current issues, and future directions.Effect of clofibrate on the growth-kinetics of the murine P 1798(sc) lymphoma.Interaction of some peroxisome proliferators with the mouse liver peroxisome proliferator-activated receptor (PPAR): a molecular modelling and quantitative structure-activity relationship (QSAR) study.Identification and characterization of DNA elements implicated in the regulation of CYP4A1 transcription.Multiple peroxisomal enzymatic deficiency disorders. A comparative biochemical and morphologic study of Zellweger cerebrohepatorenal syndrome and neonatal adrenoleukodystrophyComparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.Stable insulin-secreting ducts formed by reprogramming of cells in the liver using a three-gene cocktail and a PPAR agonist.Thyromimetic effect of peroxisomal proliferators in rat liver.Hepatic effects of phthalate esters and related compounds--in vivo and in vitro correlations.Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studies.Induction of the expression of the peroxisome proliferator-activated receptor alpha (PPARalpha) by clofibrate in jerboa tissues.Effects of perfluoro fatty acids on peroxisome proliferation and mitochondrial size in mouse liver: dose and time factors and effect of chain length.Selective oxidative stress in brain areas of neonate rats exposed to 2,4-Dichlorophenoxyacetic acid through mother's milk.Plasma protein changes in rats treated with hypolipidaemic drugs and with phthalate esters.Peroxisome Proliferators: Species Differences in Response of Primary Hepatocyte Cultures
P2860
Q34338001-707E7137-FA4F-4482-9A2C-317049395D21Q34560275-7F9D3E1F-94ED-43A5-B42F-F3F2925F1364Q34659140-B54955BA-547D-4FC8-8832-2A4F902C2AE4Q34661224-7A1DDE37-8F1F-422D-93F2-174235D7A17DQ34661276-D6C8DE52-CC6D-4F48-8D08-28C17687A1EDQ35034202-5B6FA203-4CD3-41F9-95DD-5CE4A0511CE9Q35774272-1248C159-9290-4215-A1F2-9A944DC37D40Q36059868-754DCF36-1236-4585-850B-F99136FFE651Q36465974-CFB6B8A5-6BA2-430C-A494-02A570E47BA8Q38020789-70014403-1DDC-46AE-B999-D15E3826E0A7Q38719077-34665E8C-1F8F-4252-9C82-E9ACB4E66136Q38769611-CD1CBFFB-2FA1-4EFF-B263-173D4DF86D34Q39642120-9E802E2E-2477-4A66-B51D-6C9F6E6F06AEQ39664238-0699E451-8204-4C58-87E8-912A2C0E2772Q40155146-FE583719-5D61-4E06-BEDB-870D55DA934BQ40189527-A9761EA4-CE44-4E29-8962-30871523C76EQ40200372-CCCE2764-621E-4200-B79B-77BDC0729D46Q40347797-A408BEE9-B9C0-4F06-8131-A330C2C0CDD0Q40594132-2247DC9F-E03B-4CFC-B913-B88B5B28A145Q40930928-F9146840-E590-42D5-A2FF-9F0394459D05Q41510983-98C71971-156F-440D-9BEF-6088D27D0C35Q41582795-8997FA84-30D5-475F-8A1E-77599ACA5188Q41782303-CADC0BFC-A9F3-43AA-B61B-2E9E16154C74Q41806915-05EF947C-C8DE-4A41-8F80-81F65AC1A1D0Q41832002-546D26C0-B657-464D-8485-1668984C532FQ41850316-C9998EA8-5EA4-4A01-B678-88B16BF33806Q42161959-6744EE54-125C-44F3-8113-0D2D145AB597Q42417408-FB99BC22-F5A7-4C26-8A99-6B6504C930D6Q42723223-30677191-7253-4734-A7AA-A85A2C66EF57Q44436769-CA4E9767-FDA7-4A67-8532-A8EC26A79F39Q47391757-5ABE9976-9273-47C5-A38B-A8E1E7EB37B3Q48238957-0724C433-DE2A-4C04-A993-470F24B771B2Q54162987-27F04E27-82B3-4D92-8EE6-B8B914329251Q58417458-42AA73E3-0D66-43BD-9DDA-12A39A997375
P2860
Review of the hepatic response to hypolipidaemic drugs in rodents and assessment of its toxicological significance to man.
description
1981 nî lūn-bûn
@nan
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
1981年论文
@zh
1981年论文
@zh-cn
name
Review of the hepatic response ...... cological significance to man.
@en
type
label
Review of the hepatic response ...... cological significance to man.
@en
prefLabel
Review of the hepatic response ...... cological significance to man.
@en
P1476
Review of the hepatic response ...... cological significance to man.
@en
P2093
P304
P356
10.1016/0015-6264(81)90509-5
P577
1981-10-01T00:00:00Z